Neuroscience Daily: 5-minute briefing

Neuroscience Daily for 18 September: Schizophrenia Autoantibodies, Germany Neurotech, Height Avoidance

September 18, 2026·3 min
Episode Description from the Publisher

Neuroscience Daily for 18 September follows 3 stories from r/neuro and r/neuroscience, moving through schizophrenia autoantibodies, germany neurotech, height avoidance. Chapters 00:00:00 — Intro 00:00:13 — Schizophrenia Autoantibodies 00:01:27 — Germany Neurotech 00:02:23 — Height Avoidance 00:03:21 — Closing 1. Schizophrenia Autoantibodies The first story is a bioRxiv study asking how immune activity may relate to schizophrenia. Researchers used a proteome-scale assay to profile autoantibodies in 352 people with schizophrenia and 971 community controls. Source link Reddit discussion 2. Germany Neurotech The second story is a community-made map of neurotechnology companies in Germany and Austria. The post catalogs 59 organizations working across digital therapeutics, EEG, neuromodulation, neuroimaging, rehabilitation, surgical tools, and assistive technology. Source link Reddit discussion 3. Height Avoidance The third story is a bioRxiv preprint on how mice avoid heights. Researchers built a virtual pole-descent task that let mice repeat height-related choices without quickly habituating to the situation. Source link Reddit discussion That's it for today.

Podzilla Summary coming soon

Sign up to get notified when the full AI-powered summary is ready.

Get Free Summaries →

Free forever for up to 3 podcasts. No credit card required.

Listen to This Episode

Get summaries like this every morning.

Free AI-powered recaps of Neuroscience Daily: 5-minute briefing and your other favorite podcasts, delivered to your inbox.

Get Free Summaries →

Free forever for up to 3 podcasts. No credit card required.